menu
    • menu

    Company profile for Inimmune

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inimmune was founded in early 2016 by Drs. Jay Evans, David Burkhart, Helene Bazin-Lee, Kendal Ryter, and a team of 11 highly trained scientists. It is located in Missoula, MT, and works in close collaboration with the Center for Translational Medicine at the University of Montana as well as several industry and academia partners. Inimmune is a promising new biotechnology company founded by pharmaceutical industry veterans, fo...
    Inimmune was founded in early 2016 by Drs. Jay Evans, David Burkhart, Helene Bazin-Lee, Kendal Ryter, and a team of 11 highly trained scientists. It is located in Missoula, MT, and works in close collaboration with the Center for Translational Medicine at the University of Montana as well as several industry and academia partners. Inimmune is a promising new biotechnology company founded by pharmaceutical industry veterans, focused on developing the next generation of vaccines and immunotherapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InimmuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1121 E Broadway St, Ste 106, Missoula, MT, 59802
    Telephone
    Telephone
    +1 4065415913
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inimmune.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inimmune/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inimmune Completes INI-2004 P2 Enrollment for Allergic Rhinitis
    Inimmune Completes INI-2004 P2 Enrollment for Allergic Rhinitis

    12 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inimmune-completes-enrollment-and-doses-first-patient-in-phase-2-chamber-trial-of-ini-2004-for-allergic-rhinitis-302711620.html

    PR NEWSWIRE
    12 Mar 2026
    Share Share
    Inimmune Bolsters Leadership For INI-2004 Allergic Rhinitis
    Inimmune Bolsters Leadership For INI-2004 Allergic Rhinitis

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inimmune-strengthens-leadership-team-ahead-of-phase-2-ini-2004-allergic-rhinitis-data-readout-302704508.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    Inimmune Starts Key Ph 2 Trial of INI-2004 for Allergic Rhinitis
    Inimmune Starts Key Ph 2 Trial of INI-2004 for Allergic Rhinitis

    07 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/inimmune-commences-pivotal-phase-2-allergy-trial-of-ini-2004-in-allergic-rhinitis-patients-302654429.html

    PR NEWSWIRE BIO
    07 Jan 2026
    Share Share
    SPI Pharma & Inimmune to Develop &Commercialize Vaccine Adjuvant
    SPI Pharma & Inimmune to Develop &Commercialize Vaccine Adjuvant

    17 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/spi-pharma-inc-and-inimmune-corp-partner-to-develop-and-commercialize-innovative-vaccine-adjuvant-systems-302198093.html

    PR NEWSWIRE
    17 Jul 2024
    Share Share
    INIMMUNE Reports Successful Phase 1 For Allergy Treatment INI-2004
    INIMMUNE Reports Successful Phase 1 For Allergy Treatment INI-2004

    15 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inimmune-announces-successful-phase-1-clinical-results-for-disease-modifying-allergy-treatment-ini-2004-302145985.html

    PR NEWSWIRE
    15 May 2024
    Share Share
    Inimmune Collaborates with Boston Children's Hospital to Develop Novel Adjuvants
    Inimmune Collaborates with Boston Children's Hospital to Develop Novel Adjuvants

    24 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inimmune-collaborates-with-boston-childrens-hospital-to-develop-novel-adjuvants-301965590.html

    PR NEWSWIRE
    24 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search